Lori Hazlehurst: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Targeting the bone marrow microenvironment in hematologic malignancies

William S Dalton, Lori Hazlehurst, Kenneth Shain, Terry Landowski, Melissa Alsina

Journal:

Seminars in Hematology

Year:

2004

Language:

english

File:

PDF, 207 KB

english, 2004

2

The bone marrow microenvironment as a sanctuary for minimal residual disease in CML

Rajesh R. Nair, Joel Tolentino, Lori A. Hazlehurst

Journal:

Biochemical Pharmacology

Year:

2010

Language:

english

File:

PDF, 332 KB

english, 2010

3

MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma

Emmons, Michael F., Anreddy, Nagaraju, Cuevas, Javier, Steinberger, Kayla, Yang, Shengyu, McLaughlin, Mark, Silva, Ariosto, Hazlehurst, Lori A.

Journal:

Scientific Reports

Year:

2017

Language:

english

File:

PDF, 2.33 MB

english, 2017

4

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

Hazlehurst, Lori A, Landowski, Terry H, Dalton, William S

Journal:

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

5

Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

Damiano, Jason S., Cress, Anne E., Hazlehurst, Lori A., Shtil, Alexander A., Dalton, William S.

Journal:

Year:

1999

Language:

english

File:

PDF, 256 KB

english, 1999

6

Potentiation of Nilotinib-mediated cell death in the context of the bone marrow microenvironment requires a promiscuous JAK inhibitor in CML

Rajesh R. Nair, Joel H. Tolentino, Raul F. Argilagos, Ling Zhang, Javier Pinilla-Ibarz, Lori A. Hazlehurst

Journal:

Leukemia Research

Year:

2012

Language:

english

File:

PDF, 753 KB

english, 2012

7

The one-two punch: Combination treatment in chronic myeloid leukemia

Sweet, Kendra L., Hazlehurst, Lori A., Pinilla-Ibarz, Javier

Journal:

Critical Reviews in Oncology/Hematology

Year:

2013

Language:

english

File:

PDF, 1.11 MB

english, 2013

8

[IEEE 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Vancouver, BC (2008.08.20-2008.08.25)] 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society - Towards a framework for analysis of biophotonic images of mouse models of cancer

Kamath, Vidya, Goldgof, Dmitry, Argilagos, Raul, Hazlehurst, Lori, Eschrich, Steven

Year:

2008

Language:

english

File:

PDF, 761 KB

english, 2008

9

Role of STAT3 in Transformation and Drug Resistance in CML

Nair, Rajesh R., Tolentino, Joel H., Hazlehurst, Lori A.

Journal:

Frontiers in Oncology

Year:

2012

Language:

english

File:

PDF, 942 KB

english, 2012

10

Pharmacology || Drug Resistance

Hazlehurst, Lori

Year:

2009

Language:

english

File:

PDF, 1.39 MB

english, 2009

11

Multiple Myeloma: New Insights and Therapeutic Approaches

Anderson, Kenneth C., Kyle, Robert A., Dalton, William S., Landowski, Terry, Shain, Kenneth, Jove, Richard, Hazlehurst, Lori, Berenson, James

Journal:

Hematology (American Society of Hematology)

Year:

2000

File:

PDF, 196 KB

2000

12

A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Sweet, Kendra, Hazlehurst, Lori, Sahakian, Eva, Powers, John, Nodzon, Lisa, Kayali, Fadi, Hyland, Kelly, Nelson, Ashley, Pinilla-Ibarz, Javier

Journal:

Leukemia Research

Year:

2018

Language:

english

File:

PDF, 512 KB

english, 2018

13

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

Elizabeth R. Remily-Wood, Richard Z. Liu, Yun Xiang, Yi Chen, C. Eric Thomas, Neal Rajyaguru, Laura M. Kaufman, Joana E. Ochoa, Lori Hazlehurst, Javier Pinilla-Ibarz, Jeffrey Lancet, Guolin Zhang, Eri

Journal:

PROTEOMICS - Clinical Applications

Year:

2011

Language:

english

File:

PDF, 1.02 MB

english, 2011

14

Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 a strategy for treatment of multiple myeloma

Hayes, Karen, Batsomboon, Paratchata, Chen, Wei-Chih, Becker, Andreas, Escherich, Steven, Yang, Yan, Robart, Aaron R., Dudley, Gregory, Geldenhuys, Werner J., Hazlehurst, Lori A

Journal:

Bioorganic & Medicinal Chemistry

Year:

2019

Language:

english

File:

PDF, 1.49 MB

english, 2019

15

Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma

Anreddy, Nagaraju, Hazlehurst, Lori A

Journal:

Journal of Cellular Biochemistry

Year:

2016

Language:

english

File:

PDF, 630 KB

english, 2016

16

Stable and Potent Selenomab-Drug Conjugates

Li, Xiuling, Nelson, Christopher G., Nair, Rajesh R., Hazlehurst, Lori, Moroni, Tina, Martinez-Acedo, Pablo, Nanna, Alex R., Hymel, David, Burke, Terrence R., Rader, Christoph

Journal:

Cell Chemical Biology

Year:

2017

Language:

english

File:

PDF, 2.74 MB

english, 2017

17

Signaling Networks Associated with BCR–ABL–Dependent Transformation

Hazlehurst, Lori A., Bewry, Nadine N., Nair, Rajesh R., Pinilla-Ibarz, Javier

Journal:

Year:

2009

Language:

english

File:

PDF, 393 KB

english, 2009

18

Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: Aza-anthracenediones

Lori A. Hazlehurst, A.Paul Krapcho, Miles P. Hacker

Journal:

Year:

1995

Language:

english

File:

PDF, 2.87 MB

english, 1995

19

A Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor

Caulfield, Thomas R., Hayes, Karen E., Qiu, Yushi, Coban, Mathew, Seok Oh, Joon, Lane, Amy L., Yoshimitsu, Takehiko, Hazlehurst, Lori, Copland, John A., Tun, Han W.

Journal:

Year:

2020

File:

PDF, 7.52 MB

2020

20

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab

Chen, Wei-Chih, Kanate, Abraham S, Craig, Michael, Petros, William P, Hazlehurst, Lori A

Journal:

Cancer Management and Research

Year:

2017

Language:

english

File:

PDF, 430 KB

english, 2017

21

CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo

Turner, Joel G., Dawson, Jana, Emmons, Michael F., Cubitt, Christopher L., Kauffman, Michael, Shacham, Sharon, Hazlehurst, Lori A., Sullivan, Daniel M.

Journal:

Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 1.14 MB

english, 2013

22

Comparison of AZA-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cells

Lori A. Hazlehurst, A.Paul Krapcho, Miles P. Hacker

Journal:

Biochemical Pharmacology

Year:

1995

Language:

english

File:

PDF, 959 KB

english, 1995

23

High-content screen using zebrafish ( Danio rerio ) embryos identifies a novel kinase activator and inhibitor

Geldenhuys, Werner J., Bergeron, Sadie A., Mullins, Jackie E., Aljammal, Rowaa, Gaasch, Briah L., Chen, Wei-Chi, Yun, June, Hazlehurst, Lori A.

Journal:

Bioorganic & Medicinal Chemistry Letters

Year:

2017

Language:

english

File:

PDF, 2.64 MB

english, 2017

24

The cytoplasmic trafficking of DNA topoisomerase IIα correlates with etoposide resistance in human myeloma cells

Roxane Engel, Nikola I Valkov, Jana L Gump, Lori Hazlehurst, William S Dalton, Daniel M Sullivan

Journal:

Experimental Cell Research

Year:

2004

Language:

english

File:

PDF, 690 KB

english, 2004

25

Smoking-Cessation Assistance: Before and After Stage 1 Meaningful Use Implementation

Bailey, Steffani R., Heintzman, John D., Marino, Miguel, Jacob, R. Lorie, Puro, Jon E., DeVoe, Jennifer E., Burdick, Tim E., Hazlehurst, Brian L., Cohen, Deborah J., Fortmann, Stephen P

Journal:

American Journal of Preventive Medicine

Year:

2017

Language:

english

File:

PDF, 294 KB

english, 2017

26

Contribution of the bone marrow stromal cells in mediating drug resistance in hematopoietic tumors

Chen, Wei-Chih, Hu, Gangqing, Hazlehurst, Lori A

Journal:

Current Opinion in Pharmacology

Year:

2020

File:

PDF, 688 KB

2020

27

Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies

Lori A. Hazlehurst, William S. Dalton

Journal:

Cancer and Metastasis Reviews

Year:

2001

Language:

english

File:

PDF, 229 KB

english, 2001

28

Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 a strategy for treatment of multiple myeloma

Hayes, Karen, Batsomboon, Paratchata, Chen, Wei-Chih, Becker, Andreas, Escherich, Steven, Yang, Yan, Robart, Aaron R., Dudley, Gregory, Geldenhuys, Werner J., Hazlehurst, Lori A

Journal:

Bioorganic & Medicinal Chemistry

Year:

2019

File:

PDF, 1.49 MB

2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски